Header Logo

Connection

GLENN CUNNINGHAM to Testosterone

Back to Details
This is a "connection" page, showing publications GLENN CUNNINGHAM has written about Testosterone.
GLENN CUNNINGHAM
Connection Strength
6.355
Testosterone
  1. Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled Trial. J Clin Endocrinol Metab. 2019 12 01; 104(12):6238-6246.
    View in: PubMed
    Score: 0.457
  2. EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM. Endocr Pract. 2017 May; 23(5):557-565.
    View in: PubMed
    Score: 0.377
  3. Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels. J Clin Endocrinol Metab. 2016 08; 101(8):3096-104.
    View in: PubMed
    Score: 0.360
  4. Testosterone and metabolic syndrome. Asian J Androl. 2015 Mar-Apr; 17(2):192-6.
    View in: PubMed
    Score: 0.329
  5. Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trials. J Clin Endocrinol Metab. 2015 Mar; 100(3):1146-55.
    View in: PubMed
    Score: 0.325
  6. Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels. Endocr Pract. 2013 Sep-Oct; 19(5):847-52.
    View in: PubMed
    Score: 0.296
  7. Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes. Diabetes Care. 2011 Jul; 34(7):1669-75.
    View in: PubMed
    Score: 0.255
  8. Testosterone replacement in men. Curr Opin Endocrinol Diabetes Obes. 2008 Aug; 15(4):364-70.
    View in: PubMed
    Score: 0.208
  9. Hypogonadism in male patients with cancer. Cancer. 2006 Jun 15; 106(12):2583-91.
    View in: PubMed
    Score: 0.180
  10. Testosterone replacement therapy for late-onset hypogonadism. Nat Clin Pract Urol. 2006 May; 3(5):260-7.
    View in: PubMed
    Score: 0.178
  11. Comparison of the growth-promoting effects of testosterone and 7-alpha-methyl-19-nor-testosterone (MENT) on the prostate and levator ani muscle of LPB-tag transgenic mice. Prostate. 2006 Mar 01; 66(4):369-76.
    View in: PubMed
    Score: 0.176
  12. Gonadal and erectile dysfunction in diabetics. Med Clin North Am. 2004 Jul; 88(4):933-45, xi.
    View in: PubMed
    Score: 0.157
  13. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 12 01; 6(12):e2348692.
    View in: PubMed
    Score: 0.151
  14. In vivo preservation of steroid specificity in CWR22 xenografts having a mutated androgen receptor. Prostate. 2003 Sep 15; 57(1):1-7.
    View in: PubMed
    Score: 0.149
  15. Cardiovascular Safety of Testosterone-Replacement Therapy. N Engl J Med. 2023 Jul 13; 389(2):107-117.
    View in: PubMed
    Score: 0.146
  16. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl. 2003 May-Jun; 24(3):299-311.
    View in: PubMed
    Score: 0.145
  17. Biomarkers and Noncalcified Coronary Artery Plaque Progression in Older Men Treated With Testosterone. J Clin Endocrinol Metab. 2020 07 01; 105(7).
    View in: PubMed
    Score: 0.119
  18. Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials. Lancet Diabetes Endocrinol. 2018 11; 6(11):879-890.
    View in: PubMed
    Score: 0.106
  19. Validity and Clinically Meaningful Changes in the Psychosexual Daily Questionnaire and Derogatis Interview for Sexual Function Assessment: Results From the Testosterone Trials. J Sex Med. 2018 07; 15(7):997-1009.
    View in: PubMed
    Score: 0.104
  20. Lessons From the Testosterone Trials. Endocr Rev. 2018 06 01; 39(3):369-386.
    View in: PubMed
    Score: 0.103
  21. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 05 01; 103(5):1715-1744.
    View in: PubMed
    Score: 0.102
  22. The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials. J Clin Endocrinol Metab. 2018 02 01; 103(2):681-688.
    View in: PubMed
    Score: 0.101
  23. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). J Sex Med. 2017 09; 14(9):1104-1115.
    View in: PubMed
    Score: 0.097
  24. Androgen and sleep-related erections. J Psychosom Res. 1997 Jun; 42(6):541-6.
    View in: PubMed
    Score: 0.096
  25. Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial. JAMA Intern Med. 2017 04 01; 177(4):471-479.
    View in: PubMed
    Score: 0.095
  26. Association of Testosterone Levels With Anemia in Older Men: A Controlled Clinical Trial. JAMA Intern Med. 2017 04 01; 177(4):480-490.
    View in: PubMed
    Score: 0.095
  27. Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone. JAMA. 2017 02 21; 317(7):708-716.
    View in: PubMed
    Score: 0.094
  28. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment. JAMA. 2017 02 21; 317(7):717-727.
    View in: PubMed
    Score: 0.094
  29. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME). Int J Clin Pract. 2016 Oct; 70(10):843-852.
    View in: PubMed
    Score: 0.092
  30. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men. BJU Int. 2017 Feb; 119(2):216-224.
    View in: PubMed
    Score: 0.091
  31. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016 Feb 18; 374(7):611-24.
    View in: PubMed
    Score: 0.088
  32. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF TESTOSTERONE AND CARDIOVASCULAR RISK. Endocr Pract. 2015 Sep; 21(9):1066-73.
    View in: PubMed
    Score: 0.085
  33. The Testosterone Trials: Seven coordinated trials of testosterone treatment in elderly men. Clin Trials. 2014 06; 11(3):362-375.
    View in: PubMed
    Score: 0.078
  34. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010 Jun; 95(6):2536-59.
    View in: PubMed
    Score: 0.059
  35. Testosterone replacement therapy and sleep-related erections in hypogonadal men. J Clin Endocrinol Metab. 1990 Mar; 70(3):792-7.
    View in: PubMed
    Score: 0.058
  36. Testosterone replacement with transdermal therapeutic systems. Physiological serum testosterone and elevated dihydrotestosterone levels. JAMA. 1989 May 05; 261(17):2525-30.
    View in: PubMed
    Score: 0.055
  37. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006 Jun; 91(6):1995-2010.
    View in: PubMed
    Score: 0.045
  38. Andropause: is androgen replacement therapy indicated for the aging male? Annu Rev Med. 2005; 56:117-37.
    View in: PubMed
    Score: 0.041
  39. New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men. J Clin Endocrinol Metab. 2004 Aug; 89(8):3821-9.
    View in: PubMed
    Score: 0.039
  40. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab. 2004 May; 89(5):2085-98.
    View in: PubMed
    Score: 0.039
  41. Androgen replacement in men with hypogonadism and erectile dysfunction. Endocrine. 2004 Mar-Apr; 23(2-3):143-8.
    View in: PubMed
    Score: 0.038
  42. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. J Clin Endocrinol Metab. 2024 Jan 18; 109(2):569-580.
    View in: PubMed
    Score: 0.038
  43. Hypogonadism and diabetes. Int J Impot Res. 2003 Aug; 15 Suppl 4:S14-20.
    View in: PubMed
    Score: 0.037
  44. Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE study. Am Heart J. 2022 03; 245:41-50.
    View in: PubMed
    Score: 0.033
  45. Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf). 2001 Jun; 54(6):739-50.
    View in: PubMed
    Score: 0.032
  46. Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab. 2000 Dec; 85(12):4500-10.
    View in: PubMed
    Score: 0.031
  47. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab. 2000 Aug; 85(8):2839-53.
    View in: PubMed
    Score: 0.030
  48. The potential for an androgen male contraceptive. J Clin Endocrinol Metab. 1979 Oct; 49(4):520-6.
    View in: PubMed
    Score: 0.028
  49. Persistence of complete spermatogenesis in the presence of low intratesticular concentrations of testosterone. Endocrinology. 1979 Jul; 105(1):177-86.
    View in: PubMed
    Score: 0.028
  50. Serum FSH, LH, and testosterone in 60Co gamma-irradiated male rats. Radiat Res. 1978 Nov; 76(2):331-8.
    View in: PubMed
    Score: 0.026
  51. Lovastatin-induced apoptosis in prostate stromal cells. J Clin Endocrinol Metab. 1997 May; 82(5):1434-9.
    View in: PubMed
    Score: 0.024
  52. Inhibition of steroid 5 alpha-reductase with finasteride: sleep-related erections, potency, and libido in healthy men. J Clin Endocrinol Metab. 1995 Jun; 80(6):1934-40.
    View in: PubMed
    Score: 0.021
  53. Recruitment and Screening for the Testosterone Trials. J Gerontol A Biol Sci Med Sci. 2015 Sep; 70(9):1105-11.
    View in: PubMed
    Score: 0.021
  54. Effects of 4-MAPC, a 5 alpha-reductase inhibitor, and cyproterone acetate on regrowth of the rat ventral prostate. Prostate. 1994 Apr; 24(4):212-20.
    View in: PubMed
    Score: 0.019
  55. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012 Aug; 87(8):766-78.
    View in: PubMed
    Score: 0.017
  56. 4-MAPC, a 5 alpha-reductase inhibitor, reduces rat ventral prostate weight, DNA, and prostatein concentrations. J Androl. 1991 Sep-Oct; 12(5):315-22.
    View in: PubMed
    Score: 0.016
  57. Age dependency of androgen and estrogen effects on incorporation of (3H)-thymidine by rat prostates in organ culture. Prostate. 1986; 8(4):349-62.
    View in: PubMed
    Score: 0.011
  58. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004 May; 89(5):2179-84.
    View in: PubMed
    Score: 0.010
  59. Steroid structural requirements for high affinity binding to human sex steroid binding protein (SBP). Steroids. 1981 Sep; 38(3):243-62.
    View in: PubMed
    Score: 0.008
  60. Differences in steroid specificity for rat androgen binding protein and the cytoplasmic receptor. Steroids. 1979 Mar; 33(3):261-76.
    View in: PubMed
    Score: 0.007
  61. 5alpha-Dihydrotestosterone binding to androgen binding protein. Effects of testosterone and other compounds in vivo and in vitro on the number of binding sites measured. J Biol Chem. 1978 Jan 10; 253(1):166-9.
    View in: PubMed
    Score: 0.006
  62. Mechanisms for the testicular hypertrophy which follows hemicastration. Endocrinology. 1978 Jan; 102(1):16-23.
    View in: PubMed
    Score: 0.006
  63. An FSH and prolactin-secreting pituitary tumor: pituitary dynamics and testicular histology. J Clin Endocrinol Metab. 1977 Feb; 44(2):248-53.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.